The role of the tumor microenvironment in endocrine therapy resistance in hormone receptor-positive breast cancer
J Yuan, L Yang, Z Li, H Zhang, Q Wang… - Frontiers in …, 2023 - frontiersin.org
Endocrine therapy is the prominent strategy for the treatment of hormone-positive breast
cancers. The emergence of resistance to endocrine therapy is a major health concern …
cancers. The emergence of resistance to endocrine therapy is a major health concern …
Multi-omics analysis of DNA replication-associated primase polymerase (PRIMPOL) in pan-cancer: a potential target for prognosis and immune response
L Deng, A Thakur, J Peng, L Song, Z Li - European Journal of Medical …, 2023 - Springer
Background It is critical to understand the mechanisms of human cancers in order to develop
the effective anti-cancer therapeutic strategies. Recent studies indicated that primase …
the effective anti-cancer therapeutic strategies. Recent studies indicated that primase …
New emerging targets in osteosarcoma therapy: PTEN and PI3K/Akt crosstalk in carcinogenesis
M Sadrkhanloo, MDA Paskeh, M Hashemi… - … -Research and Practice, 2023 - Elsevier
Osteosarcoma (OS) is a malignant bone carcinoma that affects people in childhood and
adulthood. The heterogeneous nature and chromosomal instability represent certain …
adulthood. The heterogeneous nature and chromosomal instability represent certain …
METTL3-mediated m6A modification of lnc KCNQ1OT1 promotes doxorubicin resistance in breast cancer by regulating miR-103a-3p/MDR1 axis
Z Zhou, Y Cao, Y Yang, S Wang, F Chen - Epigenetics, 2023 - Taylor & Francis
Doxorubicin (DOX) resistance in breast cancer (BC) poses a huge challenge for the
therapeutic effect on BC. Lnc KCNQ1OT1 play crucial roles in chemotherapy resistance …
therapeutic effect on BC. Lnc KCNQ1OT1 play crucial roles in chemotherapy resistance …
[HTML][HTML] Liquid-liquid phase separation-related lncRNA prognostic signature and ZNF32-AS2 as a novel biomarker in hepatocellular carcinoma
W Peng, Y Li, B Cheng, M Cao, L Liu, Y Yang… - Computers in Biology …, 2024 - Elsevier
Background Liquid-liquid phase separation (LLPS) enhances oncogenic signaling
pathways and advances cancer progression, and has been proposed as a promising cancer …
pathways and advances cancer progression, and has been proposed as a promising cancer …
A prognostic exosome-related long non-coding RNAs risk model related to the immune microenvironment and therapeutic responses for patients with liver …
Y Yue, J Tao, D An, L Shi - Heliyon, 2024 - cell.com
Background Liver hepatocellular carcinoma (LIHC) is the third largest cause of cancer
mortality. Exosomes are vital regulators in the development of cancer. However, the …
mortality. Exosomes are vital regulators in the development of cancer. However, the …
LncRNA FAM83A-AS1 promotes epithelial–mesenchymal transition of pancreatic cancer cells via Hippo pathway
H Wang, Y Ding, Q Zhu, Z Yu, Q Wang, A Gong, M Xu - Cell Cycle, 2023 - Taylor & Francis
ABSTRACT Background Long non-coding RNAs (lncRNAs) have been proved to play a vital
role in pancreatic cancer (PC). However, the role of lncRNA FAM83A-AS1 in PC remains …
role in pancreatic cancer (PC). However, the role of lncRNA FAM83A-AS1 in PC remains …
T Cell and Natural Killer Cell Membrane-Camouflaged Nanoparticles for Cancer and Viral Therapies
Extensive research has been conducted on the application of nanoparticles in the treatment
of cancer and infectious diseases. Due to their exceptional characteristics and flexible …
of cancer and infectious diseases. Due to their exceptional characteristics and flexible …
CircLDLRAD3 inhibits Oral squamous cell carcinoma progression by regulating miR‐558/Smad4/TGF‐β
X Zhang, GY Guo, RY Liu, T Wu… - Journal of Cellular …, 2023 - Wiley Online Library
Oral squamous cell carcinoma (OSCC) is a malignant neoplasm with high mortality and
morbidity. The role of circRNA and its molecular mechanism in OSCC remains largely …
morbidity. The role of circRNA and its molecular mechanism in OSCC remains largely …
Autophagy flux in bladder cancer: Cell death crosstalk, drug and nanotherapeutics
K Liu, H Chen, Y Li, B Wang, Q Li, L Zhang, X Liu… - Cancer Letters, 2024 - Elsevier
Autophagy, a self-digestion mechanism, has emerged as a promising target in the realm of
cancer therapy, particularly in bladder cancer (BCa), a urological malignancy characterized …
cancer therapy, particularly in bladder cancer (BCa), a urological malignancy characterized …